CoChat

The effects of kisspeptin on β‐cell function, serum metabolites and appetite in humans

Open access
Izzi‐Engbeaya, Chioma, Comninos, Alexander N., Clarke, Sophie A., Jomard, Anne, Yang, Lisa, Jones, Sophie, Abbara, Ali, Narayanaswamy, Shakunthala, Eng, Pei Chia, Papadopoulou, Deborah, Prague, Julia K., Bech, Paul, Godsland, Ian F., Bassett, Paul, Sands, Caroline, Camuzeaux, Stephane, Gomez‐Romero, Maria, Pearce, Jake T. M., Lewis, Matthew R., Holmes, Elaine, Nicholson, Jeremy K., Tan, Tricia, Ratnasabapathy, Risheka, Hu, Ming, Carrat, Gaelle, Piemonti, Lorenzo, Bugliani, Marco, Marchetti, Piero, Johnson, Paul R., Hughes, Stephen J., James Shapiro, A. M., Rutter, Guy A., Dhillo, Waljit S. · 2018 · Diabetes, Obesity and Metabolism
Cited by 94

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Aims: To investigate the effect of kisspeptin on glucose‐stimulated insulin secretion and appetite in humans. Materials and methods: In 15 healthy men (age: 25.2 ± 1.1 years; BMI: 22.3 ± 0.5 kg m −2 ), we compared the effects of 1 nmol kg −1 h −1 kisspeptin versus vehicle administration on glucose‐stimulated insulin secretion, metabolites, gut hormones, appetite and food intake. In addition, we assessed the effect of kisspeptin on glucose‐stimulated insulin secretion in vitro in human pancreatic islets and a human β‐cell line (EndoC‐βH1 cells). Results: Kisspeptin administration to healthy men enhanced insulin secretion following an intravenous glucose load, and modulated serum metabolites. In keeping with this, kisspeptin increased glucose‐stimulated insulin secretion from human islets and a human pancreatic cell line in vitro. In addition, kisspeptin administration did not alter gut hormones, appetite or food intake in healthy men. Conclusions: Collectively, these data demonstrate for the first time a beneficial role for kisspeptin in insulin secretion in humans in vivo. This has important implications for our understanding of the links between reproduction and metabolism in humans, as well as for the ongoing translational development of kisspeptin‐based therapies for reproductive and potentially metabolic conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.13460

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

Metadata

Authors
Izzi‐Engbeaya, C., Comninos, A. N., Clarke, S. A., Jomard, A., Yang, L., Jones, S., Abbara, A., Narayanaswamy, S., Eng, P. C., Papadopoulou, D., Prague, J. K., Bech, P., Godsland, I. F., Bassett, P., Sands, C., Camuzeaux, S., Gomez‐Romero, M., Pearce, J. T. M., Lewis, M. R., Holmes, E., Nicholson, J. K., Tan, T., Ratnasabapathy, R., Hu, M., Carrat, G., Piemonti, L., Bugliani, M., Marchetti, P., Johnson, P. R., Hughes, S. J., James Shapiro, A. M., Rutter, G. A., & Dhillo, W. S.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2018-08-16
Volume
20
Issue
12
Pages
2800-2810
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2881018690
Cited by
94
References
8
FWCI
10.60
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.